Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

COVID-19 cases showed a significant decrease (Mann: Whitney U test p-value < 0.001) of ascorbate (median = 2.8 µM, interquartile range (IQR) = 0.5 to 15.2) in comparison to the controls (median = 46.7 µM, IQR = 43.5 to 51.9), but neither calcidiol, retinol, nor α-tocopherol showed significant differences (Mann: Whitney U test p-value ≥ 0.181; Figure 1, Table 3).

Source: 3. Results. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Study design awaiting verification.

Study design awaiting verification

The available source does not establish a sufficiently clear study design.

Meta-analysis unclear · Blinding unclear / not reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

Clinical data and blood samples of COVID-19 patients and healthy volunteers were collected from February to November 2020 at the Cantonal Hospital of St.

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Vitamin C Deficiency in Blood Samples of COVID-19 Patients

Study design awaiting verification · Antioxidants · 2022

Original publication title

Vitamin C Deficiency in Blood Samples of COVID-19 Patients

Tobias Sinnberg; Christa Lichtensteiger; Katharina Hill-Mündel; Christian Leischner; Heike Niessner; Christian Busch; Olga Renner; Nina Wyss; Lukas Flatz; Ulrich M. Lauer; Ludwig E. Hoelzle; Donatus Nohr; Markus Burkard; Luigi Marongiu; Sascha Venturelli

© 2022 by the authors.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

At a glance

What does the authors’ abstract report?

Coronavirus disease 2019 (COVID-19) is the most notable pandemic of the modern era. A relationship between ascorbate (vitamin C) and COVID-19 severity is well known, whereas the role of other vitamins is less understood. The present study compared the blood levels of four vitamins in a cohort of COVID-19 patients with different severities and uninfected individuals. Serum concentrations of ascorbate, calcidiol, retinol, and α-tocopherol were measured in a cohort of 74 COVID-19 patients and 8 uninfected volunteers. The blood levels were statistically compared and additional co-morbidity factors were considered.

COVID-19 patients had significantly lower plasma ascorbate levels than the controls (p-value < 0.001), and further stratification revealed that the controls had higher levels than fatal, critical, and severe COVID-19 cases (p-values < 0.001). However, no such trend was observed for calcidiol, retinol, or α-tocopherol (p-value ≥ 0.093). Survival analysis showed that plasma ascorbate below 11.4 µM was associated with a lengthy hospitalization and a high risk of death. The results indicated that COVID-19 cases had depleted blood ascorbate associated with poor medical conditions, confirming the role of this vitamin in the outcome of COVID-19 infection.

Authors’ abstract

Coronavirus disease 2019 (COVID-19) is the most notable pandemic of the modern era. A relationship between ascorbate (vitamin C) and COVID-19 severity is well known, whereas the role of other vitamins is less understood. The present study compared the blood levels of four vitamins in a cohort of COVID-19 patients with different severities and uninfected individuals. Serum concentrations of ascorbate, calcidiol, retinol, and α-tocopherol were measured in a cohort of 74 COVID-19 patients and 8 uninfected volunteers. The blood levels were statistically compared and additional co-morbidity factors were considered.

COVID-19 patients had significantly lower plasma ascorbate levels than the controls (p-value < 0.001), and further stratification revealed that the controls had higher levels than fatal, critical, and severe COVID-19 cases (p-values < 0.001). However, no such trend was observed for calcidiol, retinol, or α-tocopherol (p-value ≥ 0.093). Survival analysis showed that plasma ascorbate below 11.4 µM was associated with a lengthy hospitalization and a high risk of death. The results indicated that COVID-19 cases had depleted blood ascorbate associated with poor medical conditions, confirming the role of this vitamin in the outcome of COVID-19 infection.

Publication and source details

Original title: Vitamin C Deficiency in Blood Samples of COVID-19 Patients

Tobias Sinnberg; Christa Lichtensteiger; Katharina Hill-Mündel; Christian Leischner; Heike Niessner; Christian Busch; Olga Renner; Nina Wyss; Lukas Flatz; Ulrich M. Lauer; Ludwig E. Hoelzle; Donatus Nohr; Markus Burkard; Luigi Marongiu; Sascha Venturelli

Antioxidants · 2022

* Correspondence: luigi.marongiu@uni-tuebingen.de (L.M.); sascha.venturelli@uni-hohenheim.de (S.V.); Tel.: +49-711-459-24195 (S.V.)
†

These authors contributed equally to this work.

© 2022 by the authors.2022https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).PASCOE Pharmazeutische Praeparate GmbHElse-Uebelmesser-StiftungD.30.21947Open Access Publishing Fund of the University of TuebingenThis project was funded by a grant from PASCOE Pharmazeutische Praeparate GmbH. M.B. and S.V. received a funding from the Else-Uebelmesser-Stiftung (grant no. D.30.21947, reference: GzV 1.14). We further acknowledge support by the Open Access Publishing Fund of the University of Tuebingen.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-11T09:09:58.391535+00:00

DOI: 10.3390/antiox11081580 · PMC9405075